| Repurposing drugs for the treatment and control of helminth infections G Panic, U Duthaler, B Speich, J Keiser International Journal for Parasitology: Drugs and Drug Resistance 4 (3), 185-200, 2014 | 217 | 2014 |
| Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects F Holze, P Vizeli, L Ley, F Müller, P Dolder, M Stocker, U Duthaler, ... Neuropsychopharmacology 46 (3), 537-544, 2021 | 211 | 2021 |
| Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects F Holze, L Ley, F Müller, AM Becker, I Straumann, P Vizeli, SS Kuehne, ... Neuropsychopharmacology 47 (6), 1180-1187, 2022 | 157 | 2022 |
| Acute effects of psilocybin after escitalopram or placebo pretreatment in a randomized, double‐blind, placebo‐controlled, crossover study in healthy subjects AM Becker, F Holze, T Grandinetti, A Klaiber, VE Toedtli, KE Kolaczynska, ... Clinical Pharmacology & Therapeutics 111 (4), 886-895, 2022 | 139 | 2022 |
| Trematode infections: liver and lung flukes T Fürst, U Duthaler, B Sripa, J Utzinger, J Keiser Infectious disease clinics of North America 26 (2), 399-419, 2012 | 132 | 2012 |
| Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects F Holze, U Duthaler, P Vizeli, F Müller, S Borgwardt, ME Liechti British journal of clinical pharmacology 85 (7), 1474-1483, 2019 | 84 | 2019 |
| Update on the diagnosis and treatment of food-borne trematode infections J Keiser, U Duthaler, J Utzinger Current opinion in infectious diseases 23 (5), 513-520, 2010 | 83 | 2010 |
| Anthelmintic activity of artesunate against Fasciola hepatica in naturally infected sheep J Keiser, V Veneziano, L Rinaldi, L Mezzino, U Duthaler, G Cringoli Research in veterinary science 88 (1), 107-110, 2010 | 76 | 2010 |
| Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants L Ley, F Holze, D Arikci, AM Becker, I Straumann, A Klaiber, F Coviello, ... Neuropsychopharmacology 48 (11), 1659-1667, 2023 | 65 | 2023 |
| Ketanserin reverses the acute response to LSD in a randomized, double-blind, placebo-controlled, crossover study in healthy participants AM Becker, A Klaiber, F Holze, I Istampoulouoglou, U Duthaler, ... International Journal of Neuropsychopharmacology 26 (2), 97-106, 2023 | 65 | 2023 |
| Cytochrome P450 enzymes involved in metoprolol metabolism and use of metoprolol as a CYP2D6 phenotyping probe drug B Berger, F Bachmann, U Duthaler, S Krähenbühl, M Haschke Frontiers in pharmacology 9, 774, 2018 | 64 | 2018 |
| Cytochrome P450 enzymes contribute to the metabolism of LSD to nor-LSD and 2-oxo-3-hydroxy-LSD: Implications for clinical LSD use D Luethi, MC Hoener, S Krähenbühl, ME Liechti, U Duthaler Biochemical pharmacology 164, 129-138, 2019 | 60 | 2019 |
| Fasciola hepatica: comparison of the sedimentation and FLOTAC techniques for the detection and quantification of faecal egg counts in rats U Duthaler, L Rinaldi, MP Maurelli, M Vargas, J Utzinger, G Cringoli, ... Experimental parasitology 126 (2), 161-166, 2010 | 57 | 2010 |
| Interactions between bupropion and 3, 4-methylenedioxymethamphetamine in healthy subjects Y Schmid, A Rickli, A Schaffner, U Duthaler, E Grouzmann, CM Hysek, ... Journal of Pharmacology and Experimental Therapeutics 353 (1), 102-111, 2015 | 55 | 2015 |
| Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants SB Vogt, L Ley, L Erne, I Straumann, AM Becker, A Klaiber, F Holze, ... Translational Psychiatry 13 (1), 172, 2023 | 54 | 2023 |
| Systematic evaluation of extraction methods for multiplatform-based metabotyping: application to the Fasciola hepatica metabolome J Saric, EJ Want, U Duthaler, M Lewis, J Keiser, JP Shockcor, GA Ross, ... Analytical chemistry 84 (16), 6963-6972, 2012 | 54 | 2012 |
| In Vivo and In Vitro Sensitivity of Fasciola hepatica to Triclabendazole Combined with Artesunate, Artemether, or OZ78 U Duthaler, TA Smith, J Keiser Antimicrobial agents and chemotherapy 54 (11), 4596-4604, 2010 | 53 | 2010 |
| Pharmacokinetics and pharmacodynamics of lysergic acid diethylamide microdoses in healthy participants F Holze, ME Liechti, NRPW Hutten, NL Mason, PC Dolder, EL Theunissen, ... Clinical Pharmacology & Therapeutics 109 (3), 658-666, 2021 | 50 | 2021 |
| Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers U Duthaler, C Suenderhauf, MO Karlsson, J Hussner, ... British journal of clinical pharmacology 85 (3), 626-633, 2019 | 50 | 2019 |
| Pharmacokinetics and pharmacodynamics of oral psilocybin administration in healthy participants F Holze, AM Becker, KE Kolaczynska, U Duthaler, ME Liechti Clinical Pharmacology & Therapeutics 113 (4), 822-831, 2023 | 47 | 2023 |
